An Open-label Experience Trial to Evaluate the Effects of a Novel Supplement and Hair Serum Combination on Hair, Skin and Nails in Healthy Women

• Published in: Current developments in nutrition Vol. 5; no. Supplement_2; p. 374
• Main Authors: Sylla, Sarah, Bernsley, Devon, Ojalvo, Sara Perez, Komorowski, James
• Format: Journal Article
• Language: English
• Published: Oxford Elsevier Inc 01.06.2021; Oxford University Press; Elsevier Limited
• Subjects: Dietary Bioactive Components; Dietary supplements
• ISSN: 2475-2991; 2475-2991
• DOI: 10.1093/cdn/nzab037_084

An open-label experience trial was conducted to evaluate the effects of LustrivaTM BH-002 on the health and appearance of women’s hair, skin, and nails. LustrivaTM BH-002 is a two-step system that includes dietary supplement capsules (step 1) and a hair serum (step 2) that both contain novel, highly bioavailable sources of biotin (magnesium biotinate; MgBio) and silicon (inositol-stabilized arginine silicate; ASI). In preclinical studies, the Lustriva supplement improved the hair growth cycle, levels of collagen in the skin, and skin elasticity and texture. In a three month, double-blind, placebo-controlled trial in 90 women, Lustriva capsules increased hair thickness and reduced wrinkles compared to placebo. The following open-label study was conducted to evaluate the potential benefits of the LustrivaTM BH-002 two-step system. Twelve (12) women were given a free supply of LustrivaTM BH-002 (capsules and hair serum) to use for 3 months. Each month, subjects received online survey questionnaires with questions focusing on hair, skin, and nail health. After completion of each survey questionnaire, subjects were compensated with a $25 gift card. The following results reflect participants’ responses after using LustrivaTM BH-002 for three months. Hair surveys showed that 92% of women reported an improvement in overall hair volume, 82% of women reported an improvement in hair thickness, and 75% of women reported an improvement in hair shine. Nail surveys showed that 83% of women reported an improvement in nail strength and 83% of women reported an improvement in nail growth rate. Skin surveys showed that 75% of women reported an improvement in skin smoothness, 75% of women reported an improvement in overall skin health, 83% of women reported an improvement in how satisfied they were with how healthy their facial skin looked, and 83% of women were less bothered by how noticeable the lines on their face looked. These data demonstrate that LustrivaTM BH-002, a two-step system that includes a dietary supplement and hair serum containing novel, highly absorbed biotin and silicon ingredients, improves various aspects of hair, skin, and nail health and appearance in women. This study was funded by JDS Therapeutics, LLC, the parent company of Bonafide®.